101results about How to "Reducing treatment" patented technology

In one embodiment, the present invention provides a method of reducing the viscosity of a viscosified treatment fluid comprising contacting the viscosified treatment fluid with an acid generated from an orthoester composition that comprises an orthoester. In another embodiment, the present invention provides a method of reducing the pH of a viscosified treatment fluid comprising providing an orthoester composition that comprises an orthoester; contacting the viscosified treatment fluid with the orthoester composition; allowing the orthoester to generate a generated acid; and allowing the generated acid to at least partially reduce the pH of the viscosified treatment fluid. Embodiments of fracturing and gravel packing methods also are disclosed.

A connecting means adapted to fix or release a first element (4) and a second element (5) includes a locking pin (1) which is moveable to remote activation means between a locked position. In which leg (8) expends wall (9) into recess (10), and an unlocked position. The remote activation means may be magnetic, electro-magnetic or any other suitable means. A method of fixing or releasing first and second elements by remote activation means is also disclosed. The invention further provides a first element having first means (166) adapted to cooperate with second means (165) on a second element to facilitate connection of the first and second elements. A method of manufacturing the first element includes the steps of depositing discrete amounts of setable material on a surface of the first element and inverting the element to permit the material to set under the influence of gravity. A method of reducing the spacing between first and second elements by remote activation means is also disclosed.

A bracket for orthodontic use has a base plate, a tie wing and an arch wire fitting slot. More specifically, a pair of tie wings having a pair of long and short wing pieces, i.e., a long piece and a short piece, are erected on the rectangular base plate and spaced apart, and the arch wire fitting slot is formed by the spaced apart portion. A pair of wing pieces of the tie wing are provided to project in the vertical direction with distal ends directed downward, and constituted the wing pieces include a long piece and a short piece. A recessed guide groove is provided in a vicinity of an end of the long piece.

Disclosed are methods for the treatment and / or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.

A connecting means adapted to releasably fix or release a first element (4) and a second element (5) includes a locking pin (1) which is moveable by remote activation means between a locked position, in which leg (8) expands wall (9) into recess (10), and an unlocked position. The remote activation means may be magnetic, electromagnetic or any other suitable means. There is no permanent material connection between the pin (1) and the remote activation means. A method of fixing or releasing first and second elements by remote activation means is also disclosed. The invention further provides an embodiment where the first element is a first panel and the second element is a second panel. The first panel has means (166 or 169) which co-ordinate with means (165 or 170) on the second panel. A method of manufacturing the first element includes the steps of depositing discrete amounts of setable material on a surface of the first element and inverting the element to permit the material to set under the influence of gravity. A method of reducing the spacing between first and second elements by remote activation means is also disclosed.

The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a non-vaccine treatment modality. In particular, an HSP preparation or an α2M preparation is administered in conjunction with a non-vaccine treatment modality for the treatment of cancer or infectious diseases. In the practice of the invention, a preparation comprising HSPs such as but not limited to, hsp70, hsp90 and gp96 alone or in combination with each other, noncovalently or covalently bound to antigenic molecules or α2M, noncovalently or covalently bound to antigenic molecules is administered in conjunction with a non-vaccine treatment modality.